Canada markets close in 5 hours 44 minutes

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
662.16+2.38 (+0.36%)
As of 10:15AM EDT. Market open.
Sign in to post a message.
  • F
    Funisnumberone
    Any ideas on what the drop is about today? Just regular profit taking?
  • F
    Funisnumberone
    Does IDXX see Zomedica as a threat to their business? A purchase opportunity?
  • j
    jere
    idxx frequently goes down even after good earnings. Then it recovers over the next week.
  • F
    Funisnumberone
    Yeah, a $10k box with five thyroid tests promised, three delivered. The stock jumped in January when a social influencer got paid $300 to pump the stock. It jumped, got pumped, and promptly got dumped by everybody including the exiting CEO. The blew a deal to hire a distributor sales force so now they are rushing to hire a direct sales force to cover however many vet offices there are in America with about 12 reps. THAT should be interesting! ZOM has missed all their timelines on development, delivery, and distribution so I'd love to be an IDXX rep selling against this start up. Maybe they'll get it together but done ONE THING right would be a good start. BTW, they are competing with an R&D and Sales MONSTER in the vet testing industry in IDXX. I looked with an open mind but came away thinking "not with my money".
  • J
    Jabberwonky
    Another great report.
  • T
    T
    doesn't the p/e give you any pause ?
  • Y
    Yahoo Finance Insights
    IDEXX Laboratories is down 5.38% to 666.31
  • n
    nihal
    one of the greatest ever stocks. still a long way to run. revenue potential is over $30bn by 2040 according to investor day
  • D
    Da1
    $ZOM conversation
    $ZOM is going to be the rockstar of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas, BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.

    Their new CEO Robert Cohen turned 3 companies from a 0.30 cent stock to $8, and it was already predicted before his appointment that $ZOM would become an at least $3 stock.

    YESTERDAY they applied for a Trademark for MYTRUEFORMA. Paperwork is online.

    TODAY a new Truforma webpage is up on their site, also pictures of packaging, and pre-orders are being placed at the moment. PR news could drop soon and help $ZOM reach new highs. This information has yet to catch up with the rest of the market.

    Realistic bottom right now (before any news hits) is 0.68-0.70 in my opinion, and I believe if you manage to buy around that price you should expect decent profits in the Medium to Long Term.
  • P
    Preston
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.
  • J
    Jabberwonky
    Go ahead and get ready for this one destroying earnings...
  • P
    Preston
    $ZOM conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation. GLTA
  • B
    Bagholder
    $ZOM conversation
    $ZOM is going to be the rockstar of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.

    They applied for a Trademark today for MYTRUEFORMA. Like this morning January 13th that went in. Paperwork is online.

    The CEO has taken 3 previous companies from .30 to over $8 in his career. This is not his first rodeo.
  • P
    Preston
    $ZOM conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.
  • G
    Guy
    How is IDEXX positioned to outcompete competitors? I really like this company but I’m just being cautious as there are other small companies like Lexagene LXG that seem to have a pretty solid game plan. Just looking for people to give me s reason to hold off investing even more in IDEXX.
  • W
    Walt
    $ZOM conversation
    $ZOM $IDXX Do I think the market will see further corrections? Most likely. Do I think ZOM will pull through regardless? Not just yes, but a RESOUNDING yes! Positive sales and new product info are going to bring us to new highs well within the year. Patience is the name of the game here people, and our new CEO knows what he is doing. We just got Miller distribution, a larger global accounting firm, and one of Zomedica's SEVERAL game changing products is finally about to release! Personally I will continue to buy any dips, and I think it's a poor time to sell. Things will rebound fast.
  • N
    N
    $ZOM conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.

    The target SP by March this year is at least $10 and above.
  • S
    S
    What's the reason for the spike up today? Definitely not complaining, but I can't find any info that would cause the jump.
  • N
    N
    $ZOM conversation
    *** I just came to know more about one similar device that $IDXX holds and this is 20 % less effective in diagnosis, time taken to get results, cost and portability. So, ZOMedica will surely take over the vet and pet care market with huge orders.
  • S
    Sidney
    IDXX is a great company, but at $45B market company its going to be hard for anyone investing now to get wealthy off this. Take a look at LexaGene (LXXGF). Its a sub $100M company that has revolutionary technology. Its MiQLab System can do 1 hour PCR and is in a trial run at U Penn Vet School. A large pharma just bought a system so it can detect pathogens in its bioreactors making biologics. Plus, FDA EUA for Covid19 testing anticipated in Jan 2021. Get in now and you could make generational wealth off this company.